Ulf Dittmer
#163,557
Most Influential Person Now
Researcher
Ulf Dittmer's AcademicInfluence.com Rankings
Ulf Dittmercomputer-science Degrees
Computer Science
#9611
World Rank
#10087
Historical Rank
Machine Learning
#4256
World Rank
#4305
Historical Rank
Artificial Intelligence
#4607
World Rank
#4669
Historical Rank
Database
#6580
World Rank
#6815
Historical Rank
Download Badge
Computer Science
Why Is Ulf Dittmer Influential?
(Suggest an Edit or Addition)Ulf Dittmer's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients (2020) (1357)
- Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS‐CoV, MERS‐CoV, and 2019‐nCoV (2020) (503)
- Clinical features and virological analysis of a case of Middle East respiratory syndrome coronavirus infection (2013) (395)
- Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections. (2012) (375)
- Functional impairment of CD8(+) T cells by regulatory T cells during persistent retroviral infection. (2004) (363)
- The Spike Protein of the Emerging Betacoronavirus EMC Uses a Novel Coronavirus Receptor for Entry, Can Be Activated by TMPRSS2, and Is Targeted by Neutralizing Antibodies (2013) (316)
- Hepatitis B virus suppresses toll‐like receptor–mediated innate immune responses in murine parenchymal and nonparenchymal liver cells (2009) (312)
- Susceptibility of SARS-CoV-2 to UV irradiation (2020) (270)
- Toll‐like receptor‐mediated control of HBV replication by nonparenchymal liver cells in mice (2007) (258)
- SARS-CoV-2 infection induces sustained humoral immune responses in convalescent patients following symptomatic COVID-19 (2020) (196)
- Toll‐like receptor‐induced innate immune responses in non‐parenchymal liver cells are cell type‐specific (2010) (180)
- SARS-CoV-2-specific antibody detection in healthcare workers in Germany with direct contact to COVID-19 patients (2020) (160)
- Natural Regulatory T Cells and Persistent Viral Infection (2007) (156)
- Shift of HIV tropism in stem-cell transplantation with CCR5 Delta32 mutation. (2014) (149)
- Critical Role for CD4+ T Cells in Controlling Retrovirus Replication and Spread in Persistently Infected Mice (1998) (145)
- The regulatory T-cell response during acute retroviral infection is locally defined and controls the magnitude and duration of the virus-specific cytotoxic T-cell response. (2009) (142)
- Robust T Cell Response Toward Spike, Membrane, and Nucleocapsid SARS-CoV-2 Proteins Is Not Associated with Recovery in Critical COVID-19 Patients (2020) (140)
- Mouse SAMHD1 Has Antiretroviral Activity and Suppresses a Spontaneous Cell-Intrinsic Antiviral Response (2013) (139)
- IFN‐α subtypes: distinct biological activities in anti‐viral therapy (2013) (130)
- SARS-CoV-2-specific antibody detection in healthcare workers in Germany with direct contact to COVID-19 patients (2020) (124)
- Impaired Humoral Response in Renal Transplant Recipients to SARS-CoV-2 Vaccination with BNT162b2 (Pfizer-BioNTech) (2021) (116)
- Safety and Efficacy of 48 Weeks REP 2139 or REP 2165, Tenofovir Disoproxil, and Pegylated Interferon Alfa-2a in Patients With Chronic HBV Infection Naïve to Nucleos(t)ide Therapy. (2020) (113)
- Cellular Immunity in COVID-19 Convalescents with PCR-Confirmed Infection but with Undetectable SARS-CoV-2–Specific IgG (2020) (113)
- Kinetics of CD8+ effector T cell responses and induced CD4+ regulatory T cell responses during Friend retrovirus infection (2006) (113)
- Requirement for multiple lymphocyte subsets in protection by a live attenuated vaccine against retroviral infection (1999) (107)
- Transient depletion of regulatory T cells in transgenic mice reactivates virus-specific CD8+ T cells and reduces chronic retroviral set points (2011) (105)
- Specific serology for emerging human coronaviruses by protein microarray. (2013) (102)
- Impaired Cytotoxic CD8+ T Cell Response in Elderly COVID-19 Patients (2020) (100)
- Combination of DNA Prime – Adenovirus Boost Immunization with Entecavir Elicits Sustained Control of Chronic Hepatitis B in the Woodchuck Model (2013) (97)
- Circulating HIV-Specific Interleukin-21(+)CD4(+) T Cells Represent Peripheral Tfh Cells with Antigen-Dependent Helper Functions. (2016) (96)
- Interferon Alpha Subtype-Specific Suppression of HIV-1 Infection In Vivo (2016) (95)
- vpr deletion mutant of simian immunodeficiency virus induces AIDS in rhesus monkeys (1995) (95)
- Glycyrrhizin Effectively Inhibits SARS-CoV-2 Replication by Inhibiting the Viral Main Protease (2021) (94)
- Suppression of Acute Anti-Friend Virus CD8+ T-Cell Responses by Coinfection with Lactate Dehydrogenase-Elevating Virus (2007) (94)
- Rapid development of vaccine protection in macaques by live-attenuated simian immunodeficiency virus. (1996) (93)
- Neurological Manifestations of COVID-19 Feature T Cell Exhaustion and Dedifferentiated Monocytes in Cerebrospinal Fluid (2020) (88)
- BLT-humanized C57BL/6 Rag2-/-γc-/-CD47-/- mice are resistant to GVHD and develop B- and T-cell immunity to HIV infection. (2013) (88)
- CD8+ T-Cell Dysfunction due to Cytolytic Granule Deficiency in Persistent Friend Retrovirus Infection (2005) (87)
- Excess mortality due to COVID-19 in Germany (2020) (86)
- Evolution of raltegravir resistance during therapy. (2009) (84)
- Guanylate-Binding Proteins 2 and 5 Exert Broad Antiviral Activity by Inhibiting Furin-Mediated Processing of Viral Envelope Proteins. (2019) (80)
- Characterization of a Live-Attenuated Retroviral Vaccine Demonstrates Protection via Immune Mechanisms (1998) (79)
- GNB3 c.825c>T polymorphism influences T-cell but not antibody response following vaccination with the mRNA-1273 vaccine (2022) (77)
- Humoral Response to SARS-CoV-2-Vaccination with BNT162b2 (Pfizer-BioNTech) in Patients on Hemodialysis (2021) (76)
- Interferon-α Subtypes in an Ex Vivo Model of Acute HIV-1 Infection: Expression, Potency and Effector Mechanisms (2015) (76)
- Differential expansion of circulating human MDSC subsets in patients with cancer, infection and inflammation (2020) (75)
- Regulatory T Cells Suppress Antiviral Immune Responses and Increase Viral Loads during Acute Infection with a Lymphotropic Retrovirus (2009) (75)
- Combining Regulatory T Cell Depletion and Inhibitory Receptor Blockade Improves Reactivation of Exhausted Virus-Specific CD8+ T Cells and Efficiently Reduces Chronic Retroviral Loads (2013) (73)
- Cooperativity of HIV-Specific Cytolytic CD4 T Cells and CD8 T Cells in Control of HIV Viremia (2015) (73)
- Cellular immune response of rhesus monkeys infected with a partially attenuated nef deletion mutant of the simian immunodeficiency virus. (1995) (71)
- Virus-Specific CD8+ T Cells Upregulate Programmed Death-1 Expression during Acute Friend Retrovirus Infection but Are Highly Cytotoxic and Control Virus Replication (2011) (69)
- Overcoming drug-resistant herpes simplex virus (HSV) infection by a humanized antibody (2013) (69)
- The role of CD4 and CD8 T cells in recovery and protection from retroviral infection: lessons from the Friend virus model. (2000) (67)
- GS-13-Final results of a multicenter, open-label phase 2 clinical trial (MYR203) to assess safety and efficacy of myrcludex B in cwith PEG-interferon Alpha 2a in patients with chronic HBV/HDV co-infection (2019) (66)
- Declining Levels of Neutralizing Antibodies Against SARS-CoV-2 in Convalescent COVID-19 Patients One Year Post Symptom Onset (2021) (65)
- Effects of Type I Interferons on Friend Retrovirus Infection (2006) (64)
- IFI16 Targets the Transcription Factor Sp1 to Suppress HIV-1 Transcription and Latency Reactivation. (2019) (62)
- CpG Oligodeoxynucleotides Activate HIV Replication in Latently Infected Human T Cells* (2004) (60)
- Effective Postexposure Treatment of Retrovirus-Induced Disease with Immunostimulatory DNA Containing CpG Motifs (2002) (60)
- Anti‐retroviral effects of type I IFN subtypes in vivo (2009) (59)
- Construction, replication, and immunogenic properties of a simian immunodeficiency virus expressing interleukin-2 (1997) (59)
- CD137 Agonist Therapy Can Reprogram Regulatory T Cells into Cytotoxic CD4+ T Cells with Antitumor Activity (2016) (58)
- TLR1/2 Ligand–Stimulated Mouse Liver Endothelial Cells Secrete IL-12 and Trigger CD8+ T Cell Immunity In Vitro (2013) (58)
- Essential Roles for CD8+ T Cells and Gamma Interferon in Protection of Mice against Retrovirus-Induced Immunosuppression (2002) (57)
- Temporal Effects of Gamma Interferon Deficiency on the Course of Friend Retrovirus Infection in Mice (2002) (55)
- PD-L1 Expression on Retrovirus-Infected Cells Mediates Immune Escape from CD8+ T Cell Killing (2015) (55)
- Essential role for virus-neutralizing antibodies in sterilizing immunity against Friend retrovirus infection. (2004) (55)
- Independent roles of perforin, granzymes, and Fas in the control of Friend retrovirus infection. (2004) (53)
- Cytomegalovirus reactivation in patients with refractory checkpoint inhibitor-induced colitis. (2017) (53)
- Interferon-alpha Subtype 11 Activates NK Cells and Enables Control of Retroviral Infection (2012) (53)
- Vaccination with an Adenoviral Vector That Encodes and Displays a Retroviral Antigen Induces Improved Neutralizing Antibody and CD4+ T-Cell Responses and Confers Enhanced Protection (2009) (52)
- Chemical modifications on siRNAs avoid Toll-like-receptor-mediated activation of the hepatic immune system in vivo and in vitro. (2014) (50)
- Impact of Valency of a Glycoprotein B-Specific Monoclonal Antibody on Neutralization of Herpes Simplex Virus (2010) (50)
- Role of Interleukin-4 (IL-4), IL-12, and Gamma Interferon in Primary and Vaccine-Primed Immune Responses to Friend Retrovirus Infection (2001) (50)
- COVID-19 in a lung transplant recipient (2020) (49)
- Friend retrovirus infection of myeloid dendritic cells impairs maturation, prolongs contact to naive T cells, and favors expansion of regulatory T cells. (2007) (49)
- Immune control and prevention of chronic Friend retrovirus infection. (2007) (48)
- ACE2 polymorphism and susceptibility for SARS-CoV-2 infection and severity of COVID-19 (2021) (47)
- An advanced BLT-humanized mouse model for extended HIV-1 cure studies (2018) (46)
- Silencing T cells or T-cell silencing: concepts in virus-induced immunosuppression. (2006) (46)
- TLR ligand induced IL-6 counter-regulates the anti-viral CD8+ T cell response during an acute retrovirus infection (2015) (45)
- Protection of monkeys by a split vaccine against SIVmac depends upon biological properties of the challenge virus (1993) (44)
- Opposing Development of Cytotoxic and Follicular Helper CD4 T Cells Controlled by the TCF-1-Bcl6 Nexus (2016) (43)
- CEACAM1 induces B-cell survival and is essential for protective antiviral antibody production (2015) (42)
- Hepatitis B virus sensitivity to interferon‐α in hepatocytes is more associated with cellular interferon response than with viral genotype (2018) (42)
- Allograft infiltration and meningoencephalitis by SARS-CoV-2 in a pancreas-kidney transplant recipient (2020) (42)
- CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection (2018) (41)
- Env-Independent Protection Induced by Live, Attenuated Simian Immunodeficiency Virus Vaccines (1998) (41)
- Prophylactic and therapeutic vaccination with a nanoparticle-based peptide vaccine induces efficient protective immunity during acute and chronic retroviral infection. (2014) (41)
- Repeated exposure of rhesus macaques to low doses of simian immunodeficiency virus (SIV) did not protect them against the consequences of a high-dose SIV challenge. (1995) (39)
- The Expression of PD-1 Ligands and Their Involvement in Regulation of T Cell Functions in Acute and Chronic Woodchuck Hepatitis Virus Infection (2011) (39)
- Preclinical development of TLR ligands as drugs for the treatment of chronic viral infections (2012) (39)
- Acute Resolving Woodchuck Hepatitis Virus (WHV) Infection Is Associated with a Strong Cytotoxic T-Lymphocyte Response to a Single WHV Core Peptide (2007) (38)
- The Level of Friend Retrovirus Replication Determines the Cytolytic Pathway of CD8+ T-Cell-Mediated Pathogen Control (2007) (38)
- Treatment of infectious diseases with immunostimulatory oligodeoxynucleotides containing CpG motifs. (2003) (37)
- Distinct roles of NK cells in viral immunity during different phases of acute Friend retrovirus infection (2013) (37)
- CD169+ macrophages regulate PD-L1 expression via type I interferon and thereby prevent severe immunopathology after LCMV infection (2016) (37)
- Low hepatitis B virus–specific T‐cell response in males correlates with high regulatory T‐cell numbers in murine models (2017) (36)
- Rapid Rebound of a Preexisting CXCR4-tropic Human Immunodeficiency Virus Variant After Allogeneic Transplantation With CCR5 &Dgr;32 Homozygous Stem Cells (2018) (36)
- Accelerated clearance of SHIV in rhesus monkeys by virus-like particle vaccines is dependent on induction of neutralizing antibodies. (1999) (36)
- Hepatitis B Virus-Specific CD8+ T Cells Maintain Functional Exhaustion after Antigen Reexposure in an Acute Activation Immune Environment (2018) (36)
- Differential impact of the transcriptional repressor Gfi1 on mature CD4+ and CD8+ T lymphocyte function (2007) (36)
- Activated CD8+ T Cells Induce Expansion of Vβ5+ Regulatory T Cells via TNFR2 Signaling (2014) (36)
- Complement as an Endogenous Adjuvant for Dendritic Cell-Mediated Induction of Retrovirus-Specific CTLs (2010) (36)
- Toll-Like Receptor 7 Activation Enhances CD8+ T Cell Effector Functions by Promoting Cellular Glycolysis (2019) (35)
- Coexpression of GM-CSF and antigen in DNA prime-adenoviral vector boost immunization enhances polyfunctional CD8+ T cell responses, whereas expression of GM-CSF antigen fusion protein induces autoimmunity (2008) (35)
- Enhanced cellular immune response and reduced CD8(+) lymphocyte apoptosis in acutely SIV-infected Rhesus macaques after short-term antiretroviral treatment. (2001) (35)
- Kinetics of the Development of Protective Immunity in Mice Vaccinated with a Live Attenuated Retrovirus (1999) (34)
- von Willebrand Factor Multimer Formation Contributes to Immunothrombosis in Coronavirus Disease 2019 (2021) (34)
- Persistent Control of Hepatitis B Virus and Hepatitis Delta Virus Infection Following REP 2139‐Ca and Pegylated Interferon Therapy in Chronic Hepatitis B Virus/Hepatitis Delta Virus Coinfection (2020) (34)
- The IL-1R/TLR signaling pathway is essential for efficient CD8+ T-cell responses against hepatitis B virus in the hydrodynamic injection mouse model (2017) (34)
- Transmembrane serine protease 2 Polymorphisms and Susceptibility to Severe Acute Respiratory Syndrome Coronavirus Type 2 Infection: A German Case-Control Study (2021) (33)
- 48 weeks of high dose (10 mg) bulevirtide as monotherapy or with peginterferon alfa-2a in patients with chronic HBV/HDV co-infection (2020) (33)
- IL-2–Independent and TNF-α–Dependent Expansion of Vβ5+ Natural Regulatory T Cells during Retrovirus Infection (2013) (32)
- The SARS-CoV-2 T-cell immunity is directed against the spike, membrane, and nucleocapsid protein and associated with COVID 19 severity (2020) (32)
- Protection against Establishment of Retroviral Persistence by Vaccination with a Live Attenuated Virus (1999) (32)
- Herpesvirus saimiri-transformed macaque T cells are tolerated and do not cause lymphoma after autologous reinfusion. (2000) (31)
- The PD-1/PD-L1 Pathway Affects the Expansion and Function of Cytotoxic CD8+ T Cells During an Acute Retroviral Infection (2019) (31)
- Polyinosinic-Polycytidylic Acid Treatment of Friend Retrovirus-Infected Mice Improves Functional Properties of Virus-Specific T Cells and Prevents Virus-Induced Disease (2010) (31)
- Differential Inhibitory Receptor Expression on T Cells Delineates Functional Capacities in Chronic Viral Infection (2017) (30)
- Early helper T‐cell dysfunction in simian immunodeficiency virus but not in human immunodeficiency virus type‐2‐infected macaques (1994) (30)
- Functional Comparison of Interferon‐α Subtypes Reveals Potent Hepatitis B Virus Suppression by a Concerted Action of Interferon‐α and Interferon‐γ Signaling (2020) (30)
- Preinfection Treatment of Resistant Mice with CpG Oligodeoxynucleotides Renders Them Susceptible to Friend Retrovirus-Induced Leukemia (2003) (30)
- CD4+ T Cells Develop Antiretroviral Cytotoxic Activity in the Absence of Regulatory T Cells and CD8+ T Cells (2013) (30)
- Attenuated SIV imparts immunity to challenge with pathogenic spleen-derived SIV but cannot prevent repair of the nef deletion. (1996) (30)
- Reactivation of human immunodeficiency virus type 2 in macaques after simian immunodeficiency virus SIVmac superinfection (1995) (30)
- Human pDCs display sex‐specific differences in type I interferon subtypes and interferon α/β receptor expression (2017) (29)
- Mechanisms of control of acute Friend virus infection by CD4+ T helper cells and their functional impairment by regulatory T cells. (2010) (29)
- Analysis of the Long-Term Impact on Cellular Immunity in COVID-19-Recovered Individuals Reveals a Profound NKT Cell Impairment (2021) (29)
- Regulatory T cells in retroviral infections (2018) (28)
- Advantages of Foxp3+ regulatory T cell depletion using DEREG mice (2014) (28)
- Comparable environmental stability and disinfection profiles of the currently circulating SARS-CoV-2 variants of concern B.1.1.7 and B.1.351 (2021) (28)
- Distinct roles of CD4+ T cell subpopulations in retroviral immunity: lessons from the Friend virus mouse model (2011) (28)
- Targeting the innate immunoreceptor RIG-I overcomes melanoma-intrinsic resistance to T cell immunotherapy. (2020) (28)
- Activated regulatory T cells suppress effector NK cell responses by an IL-2-mediated mechanism during an acute retroviral infection (2015) (28)
- Impact of COVID-19 on Nuclear Medicine in Germany, Austria and Switzerland: An International Survey in April 2020 (2020) (28)
- Tetherin/BST-2 promotes dendritic cell activation and function during acute retrovirus infection (2016) (26)
- MMP2/MMP9-mediated CD100 shedding is crucial for inducing intrahepatic anti-HBV CD8 T cell responses and HBV clearance. (2019) (26)
- 474 GENOMIC ANALYSIS OF THE HOST RESPONSE TO HEPATITIS B VIRUS INFECTION (2012) (26)
- Combined toll-like receptor 3/7/9 deficiency on host cells results in T-cell-dependent control of tumour growth (2017) (26)
- Evaluation of the Friend Virus model for the development of improved adenovirus-vectored anti-retroviral vaccination strategies. (2008) (25)
- Characterization of the Treg Response in the Hepatitis B Virus Hydrodynamic Injection Mouse Model (2016) (25)
- Prevention of Herpes Simplex Virus Induced Stromal Keratitis by a Glycoprotein B-Specific Monoclonal Antibody (2015) (25)
- Co-immunization of mice with a retroviral DNA vaccine and GITRL-encoding plasmid augments vaccine-induced protection against retrovirus infection. (2008) (25)
- The Cytotoxic Activity of Natural Killer Cells Is Suppressed by IL-10+ Regulatory T Cells During Acute Retroviral Infection (2018) (25)
- Replication, immunogenicity, and protective properties of live-attenuated simian immunodeficiency viruses expressing interleukin-4 or interferon-gamma. (2003) (24)
- Combination of nanoparticle-based therapeutic vaccination and transient ablation of regulatory T cells enhances anti-viral immunity during chronic retroviral infection (2016) (24)
- Modelling hepatitis D virus RNA and HBsAg dynamics during nucleic acid polymer monotherapy suggest rapid turnover of HBsAg (2020) (24)
- The influence of IFITM3 polymorphisms on susceptibility to SARS-CoV-2 infection and severity of COVID-19 (2021) (24)
- A Novel In-Cell ELISA Assay Allows Rapid and Automated Quantification of SARS-CoV-2 to Analyze Neutralizing Antibodies and Antiviral Compounds (2020) (24)
- Different immunological requirements for protection against acute versus persistent Friend retrovirus infections. (2000) (23)
- Improved vaccine protection against retrovirus infection after co-administration of adenoviral vectors encoding viral antigens and type I interferon subtypes (2011) (23)
- IFN-α Treatment Inhibits Acute Friend Retrovirus Replication Primarily through the Antiviral Effector Molecule Apobec3 (2013) (23)
- Efficient production of JC virus in SVG cells and the use of purified viral antigens for analysis of specific humoral and cellular immune response. (1997) (23)
- Immunodominance of Adenovirus-Derived CD8+ T Cell Epitopes Interferes with the Induction of Transgene-Specific Immunity in Adenovirus-Based Immunization (2017) (22)
- Plasmacytoid dendritic cells respond to Epstein-Barr virus infection with a distinct type I interferon subtype profile. (2019) (22)
- Simian Immunodeficiency Virus (SIV) gp130 Oligomers Protect Rhesus Macaques (Macaca mulatta) against the Infection with SIVmac32H Grown on T-Cells or Derivedex Vivo (1996) (22)
- Construction and Characterization of Recombinant VLPs and Semliki-Forest Virus Live Vectors for Comparative Evaluation in the SHIV Monkey Model (1999) (22)
- A patient with severe respiratory failure caused by novel human coronavirus (2013) (22)
- Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting (2021) (22)
- Tumor-specific CD4+ T cells develop cytotoxic activity and eliminate virus-induced tumor cells in the absence of regulatory T cells (2012) (21)
- A Therapeutic Antiviral Antibody Inhibits the Anterograde Directed Neuron-to-Cell Spread of Herpes Simplex Virus and Protects against Ocular Disease (2017) (21)
- Cellular and molecular mechanisms of vaccine-induced protection against retroviral infections. (2001) (21)
- The role of IL-5, IL-6 and IL-10 in primary and vaccine-primed immune responses to infection with Friend retrovirus (Murine leukaemia virus). (2001) (21)
- Turmeric Root and Its Bioactive Ingredient Curcumin Effectively Neutralize SARS-CoV-2 In Vitro (2021) (21)
- A possible role of immunopathogenesis in COVID-19 progression (2020) (20)
- Recent advances in the discovery and development of TLR ligands as novel therapeutics for chronic HBV and HIV infections (2018) (20)
- Immunoactivation induced by chronic viral infection inhibits viral replication and drives immunosuppression through sustained IFN‐I responses (2015) (20)
- COVID-19-Induced ARDS Is Associated with Decreased Frequency of Activated Memory/Effector T Cells Expressing CD11a++ (2020) (19)
- Antiviral potential of human IFN-α subtypes against influenza A H3N2 infection in human lung explants reveals subtype-specific activities (2019) (19)
- The phenotype and activation status of regulatory T cells during Friend retrovirus infection (2014) (19)
- Fas Ligand-mediated cytotoxicity of CD4+ T cells during chronic retrovirus infection (2017) (19)
- Assessing SARS-CoV-2 RNA levels and lymphocyte/T cell counts in COVID-19 patients revealed initial immune status as a major determinant of disease severity (2020) (19)
- Different antiviral effects of IFNα subtypes in a mouse model of HBV infection (2017) (19)
- Diverse Immunomodulatory Effects of Individual IFNα Subtypes on Virus-Specific CD8+ T Cell Responses (2019) (19)
- TLR2 Stimulation Increases Cellular Metabolism in CD8+ T Cells and Thereby Enhances CD8+ T Cell Activation, Function, and Antiviral Activity (2019) (18)
- Impact of low‐level BK polyomavirus viremia on intermediate‐term renal allograft function (2018) (18)
- Rapid and Sensitive SERS-Based Lateral Flow Test for SARS-CoV2-Specific IgM/IgG Antibodies. (2021) (18)
- Observational cohort study of neurological involvement among patients with SARS-CoV-2 infection (2021) (18)
- Natural regulatory T cells inhibit production of cytotoxic molecules in CD8+ T cells during low-level Friend retrovirus infection (2013) (18)
- Granulocytic myeloid-derived suppressor cells suppress virus-specific CD8+ T cell responses during acute Friend retrovirus infection (2017) (17)
- T cell apoptosis in human immunodeficiency virus type 2- and simian immunodeficiency virus-infected macaques. (1996) (17)
- Friend retrovirus drives cytotoxic effectors through Toll-like receptor 3 (2014) (16)
- Interferon α subtypes in HIV infection. (2018) (16)
- Absence of measles virus genome and transcripts in Hodgkin‐Reed/Sternberg cells of a cohort of Hodgkin lymphoma patients (2007) (16)
- PASylated interferon &agr; efficiently suppresses hepatitis B virus and induces anti‐HBs seroconversion in HBV‐transgenic mice (2019) (16)
- Simian immunodeficiency virus (SIV) gp130 oligomers protect rhesus macaques (Macaca mulatta) against the infection with SIVmac32H grown on T-cells or derived ex vivo. (1996) (16)
- NK cells improve control of friend virus infection in mice persistently infected with murine cytomegalovirus (2013) (16)
- Pasteurization Inactivates SARS-CoV-2–Spiked Breast Milk (2020) (16)
- SARS‐CoV‐2 rapid antigen test: Fast‐safe or dangerous? An analysis in the emergency department of an university hospital (2021) (16)
- Autoantibody-mediated platelet phagocytosis in SIV-infected macaques. (1994) (16)
- Distinct antiviral activities of IFN-α subtypes. (2011) (16)
- Interleukin-Encoding Adenoviral Vectors as Genetic Adjuvant for Vaccination against Retroviral Infection (2013) (16)
- Virus-specific antibodies allow viral replication in the marginal zone, thereby promoting CD8+ T-cell priming and viral control (2016) (16)
- Induction of Type I Interferons by Therapeutic Nanoparticle-Based Vaccination Is Indispensable to Reinforce Cytotoxic CD8+ T Cell Responses During Chronic Retroviral Infection (2018) (16)
- Long-term non-progressive human immunodeficiency virus infection: new insights from the simian immunodeficiency virus model. (1997) (16)
- SERINC5 Is an Unconventional HIV Restriction Factor That Is Upregulated during Myeloid Cell Differentiation (2020) (15)
- Immune monitoring facilitates the clinical decision in multifocal COVID-19 of a pancreas-kidney transplant patient (2020) (15)
- CpG oligodeoxynucleotides allow for effective adoptive T-cell therapy in chronic retroviral infection. (2007) (15)
- Dual Activity of Phosphorothioate CpG Oligodeoxynucleotides on HIV (2006) (15)
- Codelivery of the Chemokine CCL3 by an Adenovirus-Based Vaccine Improves Protection from Retrovirus Infection (2011) (15)
- Targeting Viral Antigens to CD11c on Dendritic Cells Induces Retrovirus-Specific T Cell Responses (2012) (15)
- Immunization with virion-derived glycoprotein 130 from HIV-2 or SIV protects macaques against challenge virus grown in human or simian cells or prepared ex vivo. (1994) (14)
- Disinfection of SARS-CoV-2 Contaminated Surfaces of Personal Items with UVC-LED Disinfection Boxes (2021) (14)
- Susceptibility of Different Hepatitis B Virus Isolates to Interferon-Alpha in a Mouse Model Based on Hydrodynamic Injection (2014) (14)
- Hepatitis B virus genome replication triggers toll-like receptor 3-dependent interferon responses in the absence of hepatitis B surface antigen (2016) (14)
- Filariae-Retrovirus Co-infection in Mice is Associated with Suppressed Virus-Specific IgG Immune Response and Higher Viral Loads (2016) (14)
- Woodchuck hepatitis virus core antigen-based DNA and protein vaccines induce qualitatively different immune responses that affect T cell recall responses and antiviral effects. (2015) (14)
- Generation ofHerpes Virus Saimiri-Transformed T-Cell Lines from Macaques Is Restricted by Reactivation ofSimian Spuma Viruses (1997) (14)
- Immune Response in Moderate to Critical Breakthrough COVID-19 Infection After mRNA Vaccination (2022) (13)
- Friend retrovirus studies reveal complex interactions between intrinsic, innate and adaptive immunity (2019) (13)
- Pre-exposure prophylaxis failure with tenofovir disoproxil. (2017) (13)
- Differences in the B and T cell immune response to the envelope glycoprotein 130 (gp130) of the macaque strain of simian immunodeficiency virus (SIVmac), induced by immunization of rhesus macaques with virus-derived or vaccinia virus-expressed gp130. (1993) (13)
- Clonotypic Composition of the CD4+ T Cell Response to a Vectored Retroviral Antigen Is Determined by Its Speed (2014) (12)
- A Crowned Killer’s Résumé: Genome, Structure, Receptors, and Origin of SARS-CoV-2 (2020) (12)
- Insufficient natural killer cell responses against retroviruses: how to improve NK cell killing of retrovirus-infected cells (2016) (12)
- Metabolic requirements of NK cells during the acute response against retroviral infection (2021) (12)
- Modification of One Epitope-Flanking Amino Acid Allows for the Induction of Friend Retrovirus-Specific CD8+ T Cells by Adenovirus-Based Immunization (2012) (12)
- Differential interferon-α subtype induced immune signatures are associated with suppression of SARS-CoV-2 infection (2022) (12)
- Concurrent administration of IFNα14 and cART in TKO-BLT mice enhances suppression of HIV-1 viremia but does not eliminate the latent reservoir (2019) (12)
- Complement Opsonization Enhances Friend Virus Infection of B Cells and Thereby Amplifies the Virus-Specific CD8+ T Cell Response (2010) (12)
- Immunisation strategies against prion diseases: prime-boost immunisation with a PrP DNA vaccine containing foreign helper T-cell epitopes does not prevent mouse scrapie. (2007) (12)
- No SEVI-mediated enhancement of rectal HIV-1 transmission of HIV-1 in two humanized mouse cohorts. (2016) (12)
- Characterization of Endogenous SERINC5 Protein as Anti-HIV-1 Factor (2019) (12)
- Qualitative Differences Between the IFNα subtypes and IFNβ Influence Chronic Mucosal HIV-1 Pathogenesis (2020) (11)
- Convalescent plasma treatment of critically ill intensive care COVID‐19 patients (2021) (11)
- Comment on “Premature Terminal Exhaustion of Friend Virus-Specific Effector CD8+ T Cells by Rapid Induction of Multiple Inhibitory Receptors” (2010) (11)
- Antibody-based immunotherapy of aciclovir resistant ocular herpes simplex virus infections. (2017) (11)
- SARS-CoV-2 Seroprevalence in Healthcare Workers in Germany: A Follow-Up Study (2021) (11)
- SARS‐CoV‐2‐specific humoral and cellular immunity in two renal transplants and two hemodialysis patients treated with convalescent plasma (2021) (11)
- Kinetics of lymphocyte apoptosis in macaques infected with different simian immunodeficiency viruses or simian/human immunodeficiency hybrid viruses. (1999) (10)
- Interleukin 21 augments the hepatitis B virus-specific CD8+ T-cell response in vitro in patients coinfected with HIV-1 (2012) (10)
- The analysis of the long-term impact of SARS-CoV-2 on the cellular immune system in individuals recovering from COVID-19 reveals a profound NKT cell impairment (2020) (10)
- Expanded Regulatory T Cells in Chronically Friend Retrovirus-Infected Mice Suppress Immunity to a Murine Cytomegalovirus Superinfection (2014) (10)
- Induction of T Cell Proliferation in Rhesus Macaques Immunized with Tween-Ether-Treated SIVmac and Loss of Proliferative Activity after Virus Infection (1993) (10)
- Induction of herpes simplex virus type 1 cell-to-cell spread inhibiting antibodies by a calcium phosphate nanoparticle-based vaccine. (2019) (10)
- Natural killer T cells contribute to the control of acute retroviral infection (2017) (10)
- Longitudinal characterization of phenotypic profile of T cells in chronic hepatitis B identifies immune markers associated with HBsAg loss (2021) (9)
- Glycyrrhizin effectively neutralizes SARS-CoV-2 in vitro by inhibiting the viral main protease (2020) (9)
- Different antiviral effects of IFNα and IFNβ in an HBV mouse model. (2017) (9)
- Ventricular assist device for a coronavirus disease 2019‐affected heart (2020) (9)
- Cell-mediated immune response of macaques immunized with low doses of simian immunodeficiency virus (SIV). (1996) (9)
- COVID-19 is associated with relative ADAMTS13 deficiency and VWF multimer formation resembling TTP (2020) (9)
- Effective treatment of retrovirus-induced suppression of antibody responses with CpG oligodeoxynucleotides. (2005) (9)
- Occurrence of COVID-19 Symptoms During SARS-CoV-2 Infection Defines Waning of Humoral Immunity (2021) (9)
- SARS-CoV-2-specific T cell memory is long-lasting in the majority of convalsecent COVID-19 individuals (2020) (9)
- Impact of immune suppressive agents on the BK‐Polyomavirus non coding control region (2018) (9)
- Analysis of HBsAg Immunocomplexes and cccDNA Activity During and Persisting After NAP‐Based Therapy (2021) (8)
- Alternative interpretation of lymphocyte depletion studies using monoclonal antibodies in animals previously vaccinated with attenuated retroviral vaccines. (1999) (8)
- Impaired mitogen-driven proliferation and cytokine transcription of lymphocytes from macaques early after simian immunodeficiency virus (SIV) infection. (1997) (8)
- TLR5 activation in hepatocytes alleviates the functional suppression of intrahepatic CD8+ T cells (2020) (8)
- Performance of the LIAISON® SARS-CoV-2 Antigen Assay vs. SARS-CoV-2-RT-PCR (2021) (8)
- Infection of B Cell Follicle-Resident Cells by Friend Retrovirus Occurs during Acute Infection and Is Maintained during Viral Persistence (2019) (8)
- No reactivation of attenuated immunodeficiency viruses in rhesus macaques after vaccinia virus-induced immune activation. (1997) (8)
- Evaluation of susceptibility of HIV-1 CRF01_AE variants to neutralization by a panel of broadly neutralizing antibodies (2018) (7)
- Activation of the TLR signaling pathway in CD8+ T cells counteracts liver endothelial cell-induced T cell tolerance (2019) (7)
- Peptide Receptor Radionuclide Therapy During the COVID-19 Pandemic: Are There Any Concerns? (2020) (7)
- A model to identify individuals with a high probability of a SARS-CoV-2 infection (2020) (7)
- Proceedings of the Frontiers of Retrovirology Conference 2016 (2016) (7)
- Protection of mice against Friend retrovirus infection by vaccination with antigen-loaded, spleen-derived dendritic cells. (2004) (7)
- Expression Pattern of Individual IFNA Subtypes in Chronic HIV Infection. (2017) (7)
- Hepatitis B virus particles activate B cells through the TLR2–MyD88–mTOR axis (2021) (7)
- Combination immunotherapy with anti-PD-L1 antibody and depletion of regulatory T cells during acute viral infections results in improved virus control but lethal immunopathology (2020) (7)
- Long-Term SARS-CoV-2 Specific Immunity Is Affected by the Severity of Initial COVID-19 and Patient Age (2021) (7)
- The detection of BKPyV genotypes II and IV after renal transplantation as a simple tool for risk assessment for PyVAN and transplant outcome already at early stages of BKPyV reactivation. (2019) (7)
- Imaging of cytotoxic antiviral immunity while considering the 3R principle of animal research (2018) (7)
- Live attenuated SIV vaccines are not effective in a postexposure vaccination model. (1997) (7)
- Effects of Friend Virus Infection and Regulatory T Cells on the Antigen Presentation Function of B Cells (2019) (7)
- Interference of retroviral envelope with vaccine-induced CD8+ T cell responses is relieved by co-administration of cytokine-encoding vectors (2017) (7)
- Comparison of humoral immunity and induction of proliferating T lymphocytes in vaccinia virus-infected rabbits and rhesus macaques. (1994) (6)
- Dose of Retroviral Infection Determines Induction of Antiviral NK Cell Responses (2017) (6)
- Specificity of helper T-cells generated from macaques infected with attenuated simian immunodeficiency virus. (1998) (6)
- Generation of Inhibitory Autoantibodies to ADAMTS13 in Coronavirus Disease 2019 (2021) (6)
- CD8+ T Cells Are Essential for Controlling Acute Friend Retrovirus Infection in C57BL/6 Mice (2014) (6)
- Benefit of transaminase elevations in establishing functional cure of HBV infection during nap‐based combination therapy (2021) (6)
- The prevalence of antibodies to SARS-CoV-2 in asymptomatic healthcare workers with intensive exposure to COVID-19 (2020) (6)
- Seasonality of Non-SARS, Non-MERS Coronaviruses and the Impact of Meteorological Factors (2021) (6)
- A novel in-cell ELISA assay allows rapid and automated quantification of SARS-CoV-2 to analyse neutralizing antibodies and antiviral compounds (2020) (6)
- Delivery of Toll-Like Receptor 3 Ligand Poly(I:C) to the Liver by Calcium Phosphate Nanoparticles Conjugated with an F4/80 Antibody Exerts an Anti-Hepatitis B Virus Effect in a Mouse Model. (2021) (6)
- Friend retrovirus infection induces the development of memory-like natural killer cells (2018) (5)
- Decline of Humoral Responses 6 Months after Vaccination with BNT162b2 (Pfizer–BioNTech) in Patients on Hemodialysis (2022) (5)
- Generation of HBsAg‐reactive T‐ and B‐cells following HBV vaccination in serological non‐responders under hemodialysis treatment (2020) (5)
- Torque Teno Virus load in lung cancer patients correlates with age but not with tumor stage (2021) (5)
- Inhibition of catecholamine degradation ameliorates while chemical sympathectomy aggravates the severity of acute Friend retrovirus infection in mice (2016) (5)
- Immunization of macaque monkeys with low- and high-dose regimens of SIVmac results in different immune responses. (1994) (5)
- Suppression of viral replication in a long-term nonprogressing rhesus macaque experimentally infected with pathogenic simian immunodeficiency virus (SIV). (1998) (5)
- Prechallenge high neutralizing antibodies and long-lasting immune reactivity to gp41 correlate with protection of rhesus monkeys against productive simian immunodeficiency virus infection or disease development. (1998) (5)
- Individuals With Weaker Antibody Responses After Booster Immunization Are Prone to Omicron Breakthrough Infections (2022) (5)
- A subunit vaccine consisting of gp130 oligomers but not of gp130 monomers protects rhesus macaques against productive infection with SIVmac32H. (1998) (5)
- Evaluation of the immunomodulatory and antiviral effects of the cytokine combination IFN-α and IL-7 in the lymphocytic choriomeningitis virus and Friend retrovirus mouse infection models. (2011) (5)
- Generation of herpes virus saimiri-transformed T-cell lines from macaques is restricted by reactivation of simian spuma viruses. (1997) (5)
- A Combination of Anti-PD-L1 Treatment and Therapeutic Vaccination Facilitates Improved Retroviral Clearance via Reactivation of Highly Exhausted T Cells (2021) (5)
- Distinct effects of treatment with two different interferon-alpha subtypes on HIV-1-associated T-cell activation and dysfunction in humanized mice (2021) (4)
- Different antiviral effects of IFN-αlpha subtypes in a mouse model of HBV infection (2016) (4)
- Erratum for Westmeier et al., “Impaired Cytotoxic CD8+ T Cell Response in Elderly COVID-19 Patients” (2020) (4)
- The V1 region of gp120 is preferentially selected during SIV/HIV transmission and is indispensable for envelope function and virus infection (2016) (4)
- Immunization with a murine cytomegalovirus based vector encoding retrovirus envelope confers strong protection from Friend retrovirus challenge infection (2019) (4)
- HBsAg isoform dynamics during NAP‐based therapy of HBeAg‐negative chronic HBV and HBV/HDV infection (2022) (4)
- [Prevention of thromboembolism with low molecular weight heparin (Fragmin) in obstetrics]. (1994) (4)
- Herpes Simplex Virus Type 2 Is More Difficult to Neutralize by Antibodies Than Herpes Simplex Virus Type 1 (2020) (4)
- HBeAg induces liver sinusoidal endothelial cell activation to promote intrahepatic CD8 T cell immunity and HBV clearance (2021) (4)
- Prevalence of Anti-AAV9 Antibodies in Adult Patients with Spinal Muscular Atrophy. (2022) (4)
- Natural Killer Cells Regulate the Maturation of Liver Sinusoidal Endothelial Cells Thereby Promoting Intrahepatic T‐Cell Responses in a Mouse Model (2021) (4)
- Poor clinical and virological outcome of nucleos(t)ide analogue monotherapy in HBV/HDV co-infected patients (2021) (4)
- Correction: PD-L1 Expression on Retrovirus-Infected Cells Mediates Immune Escape from CD8+ T Cell Killing (2015) (4)
- Production of HIV-1 Env-Specific Antibodies Mediating Innate Immune Functions Depends on Cognate Interleukin-21- Secreting CD4+ T Cells (2021) (4)
- Different Biological Activities of Specific Interferon Alpha Subtypes (2019) (4)
- Prophylactic and therapeutic HBV vaccination by an HBs‐expressing cytomegalovirus vector lacking an interferon antagonist in mice (2020) (3)
- Fcγ Receptor Type I (CD64)-Mediated Impairment of the Capacity of Dendritic Cells to Activate Specific CD8 T Cells by IgG-opsonized Friend Virus (2019) (3)
- Virus-specific helper T cell response of macaques immunized with inactivated whole SIV is not correlated with reactivity against cellular components of vaccine preparation. (1994) (3)
- Translation of IRF-1 Restricts Hepatic Interleukin-7 Production to Types I and II Interferons: Implications for Hepatic Immunity (2021) (3)
- The impact of hepatitis B surface antigen on natural killer cells in patients with chronic hepatitis B virus infection (2021) (3)
- Simultaneous or Prior Activation of Intrahepatic Type I Interferon Signaling Leads to Hepatitis B Virus Persistence in a Mouse Model (2021) (3)
- Cellular and Humoral Immunity against Different SARS-CoV-2 Variants Is Detectable but Reduced in Vaccinated Kidney Transplant Patients (2022) (3)
- Friend virus limits adaptive cellular immune responses by imprinting a maturation-resistant and T helper type 2-biased immunophenotype in dendritic cells (2018) (3)
- Peripheral blood iNKT cell activation correlates with liver damage during acute hepatitis C (2021) (3)
- HIV-2-specific immune status of an HIV-2-exposed but uninfected cynomolgus monkey offspring. (1994) (3)
- Holder Pasteurization Inactivates SARS-CoV-2 in Human Breast Milk (2020) (3)
- 581 HBV SUPPRESSES TLR-MEDIATED INNATE IMMUNE RESPONSES IN MURINE PARENCHYMAL AND NON-PARENCHYMAL LIVER CELLS (2008) (3)
- Silent infection of macaques inoculated with low-dose SIVmac251/spl. (1997) (3)
- Vaccination with an Adenoviral Vector That Encodes and Displays a Retroviral Antigen Induces Improved Neutralizing Antibody and CD4 (cid:1) T-Cell Responses and Confers Enhanced Protection (cid:1) (2010) (2)
- Live HIV vaccines — How safe? (1997) (2)
- Distinct Type I Interferon Subtypes Differentially Stimulate T Cell Responses in HIV-1-Infected Individuals (2022) (2)
- CCL2: a Chemokine Potentially Promoting Early Seeding of the Latent HIV Reservoir (2022) (2)
- Universally available herbal teas based on sage and perilla elicit potent antiviral activity against SARS-CoV-2 in vitro (2020) (2)
- Effects of Type I Interferons on Friend Retrovirus Infection (2007) (2)
- Immunotherapy With Interferon α11, But Not Interferon Beta, Controls Persistent Retroviral Infection (2022) (2)
- HIV infection does not alter interferon α/β receptor 2 expression on mucosal immune cells (2020) (2)
- Safety and Efficacy of 10 mg Myrcludex B/IFNa Combination Therapy in Patients with Chronic HBV/HDV Co-Infection (2020) (2)
- Antiviral CD4 cell response in simian immunodeficiency virus-infected macaques. (1998) (2)
- HBeAg Is Indispensable for Inducing Liver Sinusoidal Endothelial Cell Activation by Hepatitis B Virus (2022) (2)
- SARS-CoV-2-specific humoral and cellular immunity in renal transplant and haemodialysis patients treated with convalescent plasma (2020) (2)
- HEMATOPOIESIS AND STEM CELLS BLT-humanized C 57 BL / 6 Rag 2 2 / 2 g c 2 / 2 CD 47 2 / 2 mice are resistant to GVHD and develop Band T-cell immunity to HIV infection (2013) (2)
- Immunodeficiency Virus – Infected Macaques (2010) (2)
- Over 90% of clinical swabs used for SARS‐CoV‐2 diagnostics contain sufficient nucleic acid concentrations (2020) (2)
- Hypoxia-inducible factor 1α is Essential for Macrophage-mediated Erythroblast Proliferation in Acute Friend Retrovirus Infection (2017) (2)
- Differential interferon-α subtype immune signatures suppress SARS-CoV-2 infection (2021) (2)
- The Course of Anti-HBc Antibodies over Time in Immunocompromised Hosts (2022) (1)
- Chronic retroviral infection of mice promotes tumor development, but CD137 agonist therapy restores effective tumor immune surveillance (2019) (1)
- 1192PCytomegalovirus reactivation in patients with refractory checkpoint inhibitor-induced colitis (2017) (1)
- Reduced Frequencies and Activation of Regulatory T Cells After the Treatment of HIV-1-Infected Individuals with the CCR5 Antagonist Maraviroc Are Associated with a Reduction in Viral Loads Rather Than a Direct Effect of the Drug on Regulatory T Cells. (2016) (1)
- Fas Ligand-mediated cytotoxicity of CD4+ T cells during chronic retrovirus infection (2017) (1)
- Upregulation of miRNA-200c during Disease Progression in COVID-19 Patients (2022) (1)
- Assessing SARS-CoV-2 RNA Levels and Lymphocyte/T Cell Counts in COVID-19 Patients Revealed Initial Immune Status of Patients as a Major Determinant of Disease Severity (2020) (1)
- Identification of herbal teas and their compounds eliciting antiviral activity against SARS-CoV-2 in vitro (2022) (1)
- Comparison of Humoral and Cellular CMV Immunity in Patients Awaiting Kidney Transplantation (2021) (1)
- Natural regulatory T cells inhibit production of cytotoxic molecules in CD8+T cells during low-level Friend retrovirus infection (2013) (1)
- A rapid test recognizing mucosal SARS-CoV-2-specific antibodies distinguishes prodromal from convalescent COVID-19 (2021) (1)
- Corrigendum to "Antibody-based immunotherapy of acyclovir resistant ocular herpes simplex virus infection" [Virology 512 (2017) 194-200]. (2019) (1)
- [SARS-CoV-2 IgG seroprevalence in personnel of the extraclinical fight against the COVID-19 pandemic]. (2021) (1)
- Common respiratory viral infections: Bilateral versus unilateral bronchoalveolar lavage versus endotracheal aspiration (2020) (1)
- Cellular immune responses of macaques exposed to low doses of SIV. (1995) (1)
- Novel coronavirus associated with severe respiratory disease : Case definition and public health measures 24 (2013) (1)
- The role of soluble mediators in the clinical course of EBV infection and B cell homeostasis after kidney transplantation (2020) (1)
- Prophylactic and therapeutic HBV vaccination by an HBs-expressing cytomegalovirus vector lacking an interferon antagonist (2020) (1)
- NK cells improve control of friend virus infection in mice persistently infected with murine cytomegalovirus (2013) (1)
- Impact of Valency of a Glycoprotein B-Specific Monoclonal Antibody on Neutralization of Herpes Simplex Virus (cid:1) (2011) (0)
- A monoclonal antibody targeting the HSV-1/2 glycoprotein B inhibits the development herpes simplex virus type 1 retinitis in mice (2016) (0)
- Advantages of Foxp 3 + regulatory T cell depletion using DEREG mice Advantages of Foxp 3 + regulatory T cell depletion (2014) (0)
- ID: 34: Modulation of retrovirus-specific T cell responses by IFNα subtypes (2015) (0)
- P021: Combining Hepatitis B surface antigen (HBsAg) with Anthrax (rPA) for a single oral vaccine (2015) (0)
- Modelling hepatitis D virus RNA and HBsAg dynamics during nucleic acid polymer monotherapy suggest rapid turnover of HBsAg (2020) (0)
- SRSF1 acts as an IFN-I-regulated cellular dependency factor decisively affecting HIV-1 post-integration steps (2022) (0)
- Determined by Its Speed Response to a Vectored Retroviral Antigen Is T Cell + Clonotypic Composition of the CD4 (2014) (0)
- Patients with SARS-CoV-2-Induced Viral Sepsis Simultaneously Show Immune Activation, Impaired Immune Function and a Procoagulatory Disease State (2023) (0)
- 532 TLR-INDUCED AND CELL TYPE-SPECIFIC INNATE IMMUNE RESPONSES IN NON-PARENCHYMAL LIVER CELLS (2008) (0)
- The Role of the Inhibitory Ligand HVEM and Its Receptors CD160 and BTLA in the Regulation of Anti-retroviral T Cell Responses (2022) (0)
- Natural killer T cells contribute to the control of acute retroviral infection (2017) (0)
- Edinburgh Research Explorer Differential expansion of circulating human MDSC subsets in patients with cancer, infection and inflammation (2020) (0)
- Polymorphism of tmprss2 (rs12329760) and severity of COVID-19 in the Ukrainian population: Response. (2023) (0)
- Poor clinical and virological outcome of nucleos(t)ide therapy in HBV/HDV co-infected patients (2020) (0)
- Universally available herbal teas based on sage and perilla elicit potent antiviral activity against SARS-CoV-2 variants of concern by HMOX-1 upregulation in human cells (2022) (0)
- P022: The hepatitis B virus (HBV) surface antigen (HBsAg) prevents hepadnaviral replication‐dependent interferon responses, which are mediated by non‐parenchymal liver cells in a HBV transgenic mouse model (2015) (0)
- Antibody responses elicited by mRNA vaccination in firefighters persist six months and correlate inversely with age and directly with BMI (2022) (0)
- Granulocytic myeloid-derived suppressor cells suppress virus-specific CD8+ T cell responses during acute Friend retrovirus infection (2017) (0)
- 114 : Interferon-alpha therapy enhances the anti-friend virus B cell response through Apobec3 (2013) (0)
- The V1 region of gp120 is preferentially selected during SIV/HIV transmission and is indispensable for envelope function and virus infection (2016) (0)
- LP45 : The hepatitis B virus (HBV) surface antigen impedes hepadnaviral replication-dependent interferon responses in a HBV transgenic mouse model (2015) (0)
- Retrovirus Infection Natural Regulatory T + 5 β Expansion of V Dependent − α Independent and TNF-− IL-2 and (2013) (0)
- COVID-19 vaccination in advanced skin cancer patients receiving systemic anticancer treatment: A prospective singlecenter study investigating seroconversion rates (2022) (0)
- Polymorphism of tmprss2 (rs12329760) but not ace2 (rs4240157), tmprss11a (rs353163) and cd147 (rs8259) is associated with the severity of COVID-19 in the Ukrainian population (2023) (0)
- The CCL2 Chemokine Promotes Early Seeding of the Latent HIV Reservoir (2021) (0)
- Interferon-α subtype treatment induces the repression of SRSF1 in HIV-1 target cells and affects HIV-1 post integration steps (2021) (0)
- Longitudinal characterization of phenotypic profile of T cells in chronic hepatitis B identifies immune markers predicting HBsAg loss (2020) (0)
- Establishment and clinical validation of an in-cell-ELISA-based assay for the rapid quantification of Rabies lyssavirus neutralizing antibodies (2022) (0)
- Antiviral Effector Molecule Apobec3 the Retrovirus Replication Primarily through Treatment Inhibits Acute Friend a IFN-Mario (2013) (0)
- Impact of low eGFR on the immune response against COVID-19 (2022) (0)
- O003 Interferon alpha subtype 11 activates NK cells and enables control of retroviral infection (2012) (0)
- CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection (2018) (0)
- The phenotype and activation status of regulatory T cells during Friend retrovirus infection (2014) (0)
- Imaging of cytotoxic antiviral immunity while considering the 3R principle of animal research (2018) (0)
- Activation of the TLR signaling pathway in CD8+ T cells counteracts liver endothelial cell-induced T cell tolerance (2019) (0)
- Establishment and Clinical Validation of an In-Cell ELISA-Based Assay for the Rapid Quantification of Rabies Virus Neutralizing Antibodies (2021) (0)
- perilla elicit potent antiviral activity 1 against SARS-CoV-2 in vitro 2 3 (2020) (0)
- IFNα subtype-specific susceptibility of HBV in the course of chronic infection (2022) (0)
- NK cells regulate LSEC to promote the HBV-specific T cells response (2020) (0)
- Inhibitory Receptors'' T Cells by Rapid Induction of Multiple + CD8Exhaustion of Friend Virus-Specific Effector Comment on ''Premature Terminal (2010) (0)
- Janus kinase inhibitors modulate hepatitis E virus infection (2023) (0)
- Friend retrovirus infection induces the development of memory-like natural killer cells (2018) (0)
- Activated regulatory T cells suppress effector NK cell responses by an IL-2-mediated mechanism during an acute retroviral infection (2015) (0)
- Cell-to-cell spread inhibiting antibodies constitute a correlate of protection against herpes simplex virus type 1 reactivations: A retrospective study (2020) (0)
- ID: 41: Treatment with interferon alpha subtype 14 potently suppresses HIV infection in humanized mice (2015) (0)
- This information is current as T Cell Immunity In Vitro + CD 8 Endothelial Cells Secrete IL-12 and Trigger Stimulated Mouse Liver − TLR 1 / 2 Ligand (2013) (0)
- A systematic comparison reveals dynamic differences in early adaptive immune responses of acute‐resolving versus chronic HBV replication (2018) (0)
- Seasonality of non-SARS, non-MERS Corona viruses and the impact of meteorological factors (2020) (0)
- Role of complement in virus-specific CTL response induced by bone-marrow derived DCs (2009) (0)
- Hepatitis B virus particles activate B cells through the TLR2–MyD88–mTOR axis (2021) (0)
- Mechanisms of regulatory T cell activation and expansion utilizing virus-specific CD8+ T cells (VIR10P.1172) (2015) (0)
- Impaired humoral immunity to BQ.1.1 in convalescent and vaccinated patients (2023) (0)
- Inhibition of IL-2 or NF-κB Subunit c-Rel-Dependent Signaling Inhibits Expansion of Regulatory T Cells During Acute Friend Retrovirus Infection. (2020) (0)
- Insufficient natural killer cell responses against retroviruses: how to improve NK cell killing of retrovirus-infected cells (2016) (0)
- MONITORING OF GENERAL IMMUNE STATUS AND SARS-COV-2 REACTIVE T-CELL AND HUMORAL IMMUNITY FACILITATES THE CLINICAL DECISION IN A SEVERE SARS-COV-2-ASSOCIATED PNEUMONIA, MENINGOENCEPHALITIS AND GASTROENTERITIS IN A PANCREAS-KIDNEY TRANSPLANT PATIENT (2020) (0)
- Patients with SARS-CoV-2-Induced Viral Sepsis Show Clear Signs of Immune Activation, Accompanied by an Impaired Immune Function and a Procoagulatory Disease State (2022) (0)
- Peripheral sympathectomy affects the course and severity of Friend retrovirus infection in mice (2014) (0)
- 83 : Antiviral and immunomodulatory activity of different human interferon-α subtypes during chronic viral infections (2013) (0)
- 798 TLR2 LIGAND PAM3CSK4 INHIBITS PEPTIDE-INDUCED DELETION OF CD8 T CELLS TO VIRAL ANTIGENS IN MOUSE MODEL (2012) (0)
- P020: Signatures of T‐bet and Eomes expression on virus‐specific T‐cells in hepatitis B virus infection (2015) (0)
- Interferon-alpha subtypes differentially enhance dendritic cell biology (2007) (0)
- Hypoxia-inducible factor 1α is Essential for Macrophage-mediated Erythroblast Proliferation in Acute Friend Retrovirus Infection (2017) (0)
- Combination of nanoparticle-based therapeutic vaccination and transient ablation of regulatory T cells enhances anti-viral immunity during chronic retroviral infection (2016) (0)
- Friend retrovirus drives cytotoxic effectors through Toll-like receptor 3 (2014) (0)
- Modification of One Epitope-Flanking Amino Acid Allows for the Induction of Friend Retrovirus-Specific CD8 (cid:1) T Cells by Adenovirus-Based Immunization (2012) (0)
- HIV infection does not alter Interferon α/β receptor expression on mucosal immune cells (2019) (0)
- Replication Highly Cytotoxic and Control Virus Acute Friend Retrovirus Infection but Are Programmed Death-1 Expression during T Cells Upregulate + Virus-Specific CD 8 (2011) (0)
- Prevention of herpes simplex stromal keratitis by a glycoprotein B-specific monoclonal (2015) (0)
- Different antiviral effects of IFNα subtypes in a mouse model of HBV infection (2017) (0)
- Evaluation of susceptibility of HIV-1 CRF01_AE variants to neutralization by a panel of broadly neutralizing antibodies (2018) (0)
- COVID-19 vaccination in psoriasis patients receiving systemic treatment: A prospective single-center study (2023) (0)
- PS1-111 Interferon alpha subtype 11 selectively activates NK cells to enable control of retroviral infection (2011) (0)
- Measurement of BK-polyomavirus Non-Coding Control Region Driven Transcriptional Activity Via Flow Cytometry. (2019) (0)
- Distinct roles of NK cells in viral immunity during different phases of acute Friend retrovirus infection (2013) (0)
- Interference of retroviral envelope with vaccine-induced CD8+ T cell responses is relieved by co-administration of cytokine-encoding vectors (2017) (0)
- Long-Term Follow-Up after Adoptive Transfer of BK-Virus-Specific T Cells in Hematopoietic Stem Cell Transplant Recipients (2023) (0)
- Proceedings of the Frontiers of Retrovirology Conference 2016 (2016) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Ulf Dittmer?
Ulf Dittmer is affiliated with the following schools:
